Neuronox® is a botulinum toxin type A complex (100 Units) pharmaceutical manufactured by Medy-Tox Inc. and officially launched in Korea since 2006.
Neuronox 100iu injection is used in treatment of wrinkles muscle spasms, chronic migraine, cervical dystonia and squint.
Neuronox 100iu injection works by blocking the nerve impulses to the muscles and reduces excessive contractions of these muscles. Neuronox 100iu injection also blocks the pain signals in a migraine.
The shelf-life of NEURONOX® 100 Units is 36 months from the manufacturing date.
Active ingredient : Clostridium botulinum toxin type A 100 units(U). Stabilizer : Human serum albumin 0.5mg.
- NEURONOX® is indicated for the treatment of benign essential blepharspasm in patients 18 years of age and above.
- NEURONOX® is indicated for the treatment of equinus foot deformity due to spasticity in pediatric cerebral palsy patients 2 years of age and above.
- Temporary improvement of serious glabellar wrinkles ranging from moderate to severe associated with corrugators muscle and/or procerus muscle activities in adults over the age of 18 and below the age of 65.